Press Releases

Partnerships

French multidisciplinary consortium ARPEGE awarded public funding of close to €9 million to fight antibiotic resistance

The ARPEGE project aims to develop a set of solutions to strengthen the ability of healthcare institutions to fight antibiotic resistance. The consortium, led by Antabio, has been awarded close to €9 ...

Corporate Social Responsibility

Corporate Social Responsibility: bioMérieux recently received a series of official recognitions from independent third parties

bioMérieux, a world leader in the field of in vitro diagnostics, recently received a series of official recognitions for its achievements in Corporate Social Responsibility (CSR) from independent thir...

Financial Information

bioMérieux – Increased outlook for full-year 2021

bioMérieux, a world leader in the field of in vitro diagnostics, today released its adjusted outlook for full-year 2021. In light of stronger than expected respiratory panels sales in Q4, full-year 20...

Business & Solutions

bioMérieux molecular tests efficiently detect SARS-CoV-2 Omicron variant

As the incidence of infections with the SARS-CoV-2 Omicron variant (B.1.1. 529) continues to rise, there is much concern about diagnostic tests ability to efficiently detect this multi-mutated form of...

Partnerships

Baxter and bioMérieux announce CE mark for NEPHROCLEAR™ CCL14 test to predict persistent severe acute kidney injury

Baxter International Inc. (NYSE:BAX), a global leader in acute care, and bioMérieux (EPA:BIM), a global leader in in vitro diagnostics, today announced the CE marking of the NEPHROCLEAR™ CCL14 Test. T...

bioMérieux – Third-Quarter 2021 Business Review

bioMérieux, a world leader in the field of in vitro diagnostics, today releases its business review for the nine months ended September 30, 2021.